O	O	O	0	14	Glucocorticoid	Glucocorticoid	B-NP	NN	O	4	NMOD	O
O	O	O	14	15	-	-	B-NP	HYPH	O	1	P	O
O	O	O	15	22	induced	induce	I-NP	VBN	O	4	NMOD	O
O	O	O	23	32	apoptosis	apoptosis	I-NP	NN	O	9	SUB	O
O	O	O	33	35	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	36	41	human	human	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	O	42	50	leukemic	leukemic	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	O	51	56	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	57	59	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	60	66	caused	cause	I-VP	VBN	O	9	VC	O
O	O	O	67	69	by	by	B-PP	IN	O	10	VMOD	O
O	O	O	70	73	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	74	84	repressive	repressive	I-NP	JJ	O	14	NMOD	O
O	O	O	85	93	function	function	I-NP	NN	O	11	PMOD	O
O	O	O	94	96	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	97	100	the	the	B-NP	DT	O	18	NMOD	O
T1	B-Protein	B-Protein	101	115	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	18	NMOD	B-protein
T1	I-Protein	I-Protein	116	124	receptor	receptor	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	124	125	.	.	O	.	O	9	P	O

O	O	O	127	136	Induction	Induction	B-NP	NN	O	22	SUB	O
O	O	O	137	139	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	140	149	apoptosis	apoptosis	B-NP	NN	O	2	PMOD	O
O	O	O	150	152	in	in	B-PP	IN	O	1	NMOD	O
O	O	O	153	164	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	4	PMOD	B-cell_type
O	O	O	164	165	,	,	O	,	O	1	P	O
O	O	O	166	171	which	which	B-NP	WDT	O	1	NMOD	O
O	O	O	172	175	may	may	B-VP	MD	O	7	SBAR	O
O	O	O	176	183	account	account	I-VP	VB	O	8	VC	O
O	O	O	184	187	for	for	B-PP	IN	O	9	VMOD	O
O	O	O	188	191	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	192	203	therapeutic	therapeutic	I-NP	JJ	O	13	NMOD	O
O	O	O	204	211	effects	effect	I-NP	NNS	O	10	PMOD	O
O	O	O	212	214	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	215	230	glucocorticoids	glucocorticoid	B-NP	NNS	O	14	PMOD	O
O	O	O	231	233	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	234	241	various	various	B-NP	JJ	O	18	NMOD	O
O	O	O	242	250	diseases	disease	I-NP	NNS	O	16	PMOD	O
O	O	O	251	260	including	include	B-PP	VBG	O	18	NMOD	O
O	O	O	261	269	leukemia	leukemia	B-NP	NN	O	19	PMOD	O
O	O	O	269	270	,	,	O	,	O	1	P	O
O	O	O	271	278	depends	depend	B-VP	VBZ	O	0	ROOT	O
O	O	O	279	281	on	on	B-PP	IN	O	22	VMOD	O
O	O	O	282	285	the	the	B-NP	DT	O	26	NMOD	O
T2	B-Protein	B-Protein	286	300	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	26	NMOD	B-protein
T2	I-Protein	I-Protein	301	309	receptor	receptor	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	O	309	310	.	.	O	.	O	22	P	O

O	O	O	311	318	However	However	B-ADVP	RB	O	13	VMOD	O
O	O	O	318	319	,	,	O	,	O	13	P	O
O	O	O	320	323	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	324	330	events	event	I-NP	NNS	O	13	SUB	O
O	O	O	331	338	leading	lead	B-VP	VBG	O	4	NMOD	O
O	O	O	339	343	from	from	B-PP	IN	O	5	VMOD	O
O	O	O	344	347	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	348	357	activated	activate	I-NP	VBN	O	9	NMOD	O
O	O	O	358	366	receptor	receptor	I-NP	NN	O	6	PMOD	O
O	O	O	367	369	to	to	B-PP	TO	O	5	VMOD	O
O	O	O	370	374	cell	cell	B-NP	NN	O	12	NMOD	O
O	O	O	375	380	lysis	lysis	I-NP	NN	O	10	PMOD	O
O	O	O	381	384	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	385	388	not	not	I-VP	RB	O	13	VMOD	O
O	O	O	389	399	understood	understand	I-VP	VBN	O	13	VC	O
O	O	O	399	400	.	.	O	.	O	13	P	O

O	O	O	401	402	A	A	B-NP	DT	O	3	NMOD	O
O	O	O	403	413	prevailing	prevail	I-NP	VBG	O	3	NMOD	O
O	O	O	414	424	hypothesis	hypothesis	I-NP	NN	O	4	SUB	O
O	O	O	425	435	postulates	postulate	B-VP	VBZ	O	0	ROOT	O
O	O	O	436	445	induction	induction	B-NP	NN	O	4	OBJ	O
O	O	O	446	448	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	449	451	so	so	O	RB	O	6	PMOD	O
O	O	O	451	452	-	-	O	HYPH	O	7	PMOD	O
O	O	O	452	458	called	call	B-VP	VBN	O	8	NMOD	O
O	O	O	459	460	'	'	B-NP	''	O	12	NMOD	O
T7	B-Entity	B-Entity	460	465	lysis	lysis	I-NP	NN	B-DNA	12	NMOD	B-DNA
T7	I-Entity	I-Entity	466	471	genes	gene	I-NP	NNS	I-DNA	9	VMOD	I-DNA
O	O	O	471	472	'	'	O	''	O	12	NMOD	O
O	O	O	473	475	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	476	479	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	480	489	activated	activate	I-NP	VBN	B-protein	17	NMOD	B-protein
O	O	O	490	498	receptor	receptor	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	498	499	.	.	O	.	O	4	P	O

O	O	O	500	502	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	503	507	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	508	513	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	513	514	,	,	O	,	O	6	P	O
O	O	O	515	517	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	518	522	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	523	527	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	528	530	an	an	B-NP	DT	O	14	NMOD	O
O	O	O	531	541	activation	activation	I-NP	NN	O	14	NMOD	O
O	O	O	541	542	-	-	O	HYPH	O	14	NMOD	O
O	O	O	542	551	deficient	deficient	B-NP	JJ	O	14	NMOD	O
T3	B-Protein	B-Protein	552	566	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	14	NMOD	B-protein
T3	I-Protein	I-Protein	567	575	receptor	receptor	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	576	582	mutant	mutant	I-NP	NN	I-protein	15	SUB	I-protein
O	O	O	583	585	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	586	588	as	as	B-ADJP	RB	O	17	AMOD	O
O	O	O	589	598	effective	effective	I-ADJP	JJ	O	15	PRD	O
O	O	O	599	601	as	as	B-PP	IN	O	17	AMOD	O
O	O	O	602	605	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	606	610	wild	wild	I-NP	JJ	B-protein	23	NMOD	B-protein
O	O	O	610	611	-	-	I-NP	HYPH	I-protein	23	NMOD	I-protein
O	O	O	611	615	type	type	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	616	624	receptor	receptor	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	625	627	in	in	B-PP	IN	O	17	AMOD	O
O	O	O	628	638	repression	repression	B-NP	NN	O	24	PMOD	O
O	O	O	639	641	of	of	B-PP	IN	O	25	NMOD	O
T8	B-Entity	B-Entity	642	644	AP	AP	B-NP	NN	B-protein	30	NMOD	B-protein
T8	I-Entity	I-Entity	644	645	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T8	I-Entity	I-Entity	645	646	1	1	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	647	655	activity	activity	I-NP	NN	O	26	PMOD	O
O	O	O	655	656	,	,	O	,	O	7	P	O
O	O	O	657	667	inhibition	inhibition	B-NP	NN	O	46	NMOD	O
O	O	O	668	670	of	of	B-PP	IN	O	32	NMOD	O
T4	B-Protein	B-Protein	671	682	interleukin	interleukin	B-NP	NN	B-protein	37	NMOD	B-protein
T4	I-Protein	I-Protein	682	683	-	-	O	HYPH	I-protein	37	NMOD	I-protein
T4	I-Protein	I-Protein	683	684	2	2	B-NP	CD	I-protein	37	NMOD	I-protein
O	O	O	685	695	production	production	I-NP	NN	O	33	PMOD	O
O	O	O	695	696	,	,	O	,	O	46	P	O
O	O	O	697	707	inhibition	inhibition	B-NP	NN	O	46	NMOD	O
O	O	O	708	710	of	of	B-PP	IN	O	39	NMOD	O
T5	B-Protein	B-Protein	711	712	c	c	B-NP	NN	O	44	NMOD	O
T5	I-Protein	I-Protein	712	713	-	-	I-NP	HYPH	O	44	NMOD	O
T5	I-Protein	I-Protein	713	716	myc	myc	I-NP	NN	B-protein	44	NMOD	B-protein
O	O	O	717	727	expression	expression	I-NP	NN	O	40	PMOD	O
O	O	O	728	731	and	and	O	CC	O	46	NMOD	O
O	O	O	732	741	induction	induction	B-NP	NN	O	31	OBJ	O
O	O	O	742	744	of	of	B-PP	IN	O	46	NMOD	O
O	O	O	745	754	apoptosis	apoptosis	B-NP	NN	O	47	PMOD	O
O	O	O	754	755	.	.	O	.	O	6	P	O

O	O	O	756	767	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	O	767	768	,	,	O	,	O	4	P	O
O	O	O	769	771	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	772	776	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	777	781	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	782	790	retinoic	retinoic	B-NP	JJ	O	7	NMOD	O
O	O	O	791	795	acid	acid	I-NP	NN	O	8	SUB	O
O	O	O	796	799	can	can	B-VP	MD	O	5	SBAR	O
O	O	O	800	804	also	also	I-VP	RB	O	8	VMOD	O
O	O	O	805	811	induce	induce	I-VP	VB	O	8	VC	O
O	O	O	812	821	apoptosis	apoptosis	B-NP	NN	O	10	OBJ	O
O	O	O	822	824	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	825	830	these	these	B-NP	DT	O	14	NMOD	O
O	O	O	831	836	cells	cell	I-NP	NNS	O	12	PMOD	O
O	O	O	837	844	through	through	B-PP	IN	O	10	VMOD	O
O	O	O	845	848	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	849	857	retinoic	retinoic	I-NP	JJ	B-protein	19	NMOD	B-protein
O	O	O	858	862	acid	acid	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	863	871	receptor	receptor	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	O	871	872	,	,	O	,	O	19	P	O
O	O	O	873	878	whose	whose	B-NP	WP$	O	28	NMOD	O
O	O	O	879	889	repressive	repressive	I-NP	JJ	O	23	NMOD	O
O	O	O	890	899	functions	function	I-NP	NNS	O	28	NMOD	O
O	O	O	900	903	but	but	B-NP	CC	O	28	NMOD	O
O	O	O	904	907	not	not	I-NP	RB	O	24	DEP	O
O	O	O	908	914	target	target	B-NP	NN	O	28	NMOD	O
O	O	O	915	919	site	site	I-NP	NN	O	28	NMOD	O
O	O	O	920	931	specificity	specificity	I-NP	NN	O	15	PMOD	O
O	O	O	931	932	,	,	O	,	O	10	P	O
O	O	O	933	936	are	be	B-VP	VBP	O	10	VMOD	O
O	O	O	937	944	similar	similar	B-ADJP	JJ	O	30	PRD	O
O	O	O	945	947	to	to	B-PP	TO	O	31	AMOD	O
O	O	O	948	953	those	those	B-NP	DT	O	32	PMOD	O
O	O	O	954	956	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	957	960	the	the	B-NP	DT	O	37	NMOD	O
T6	B-Protein	B-Protein	961	975	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	37	NMOD	B-protein
T6	I-Protein	I-Protein	976	984	receptor	receptor	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	O	984	985	.	.	O	.	O	4	P	O

O	O	O	986	995	Therefore	Therefore	B-ADVP	RB	O	14	VMOD	O
O	O	O	995	996	,	,	O	,	O	14	P	O
O	O	O	997	1000	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1001	1008	primary	primary	I-NP	JJ	O	5	NMOD	O
O	O	O	1009	1015	effect	effect	I-NP	NN	O	14	SUB	O
O	O	O	1016	1018	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1019	1022	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1023	1031	receptor	receptor	I-NP	NN	O	6	PMOD	O
O	O	O	1032	1034	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1035	1049	glucocorticoid	glucocorticoid	B-NP	NN	O	13	NMOD	O
O	O	O	1049	1050	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	1050	1058	mediated	mediate	I-NP	VBN	O	13	NMOD	O
O	O	O	1059	1068	apoptosis	apoptosis	I-NP	NN	O	9	PMOD	O
O	O	O	1069	1079	correlates	correlate	B-VP	VBZ	O	0	ROOT	O
O	O	O	1080	1084	with	with	B-PP	IN	O	14	VMOD	O
O	O	O	1085	1100	transcriptional	transcriptional	B-NP	JJ	O	17	NMOD	O
O	O	O	1101	1111	repression	repression	I-NP	NN	O	20	NMOD	O
O	O	O	1112	1118	rather	rather	B-CONJP	RB	O	20	NMOD	O
O	O	O	1119	1123	than	than	I-CONJP	IN	O	18	DEP	O
O	O	O	1124	1134	activation	activation	B-NP	NN	O	15	PMOD	O
O	O	O	1135	1138	and	and	O	CC	O	14	VMOD	O
O	O	O	1139	1144	could	could	B-VP	MD	O	14	VMOD	O
O	O	O	1145	1147	be	be	I-VP	VB	O	22	VC	O
O	O	O	1148	1156	mediated	mediate	I-VP	VBN	O	23	VC	O
O	O	O	1157	1159	by	by	B-PP	IN	O	24	VMOD	O
O	O	O	1160	1172	interference	interference	B-NP	NN	O	25	PMOD	O
O	O	O	1173	1177	with	with	B-PP	IN	O	26	NMOD	O
O	O	O	1178	1183	other	other	B-NP	JJ	O	27	PMOD	O
O	O	O	1184	1197	transcription	transcription	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	1198	1205	factors	factor	I-NP	NNS	I-protein	28	NMOD	I-protein
O	O	O	1206	1214	required	require	B-VP	VBN	O	28	NMOD	O
O	O	O	1215	1218	for	for	B-PP	IN	O	31	VMOD	O
O	O	O	1219	1223	cell	cell	B-NP	NN	O	34	NMOD	O
O	O	O	1224	1232	survival	survival	I-NP	NN	O	32	PMOD	O
O	O	O	1232	1233	.	.	O	.	O	14	P	O
